Homo sapiens Protein: ATM | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||||||||||||||||||||||
InnateDB Protein | IDBP-382900.5 | ||||||||||||||||||||||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||||||||||||||||||||||
Gene Symbol | ATM | ||||||||||||||||||||||||||||||||||||||||||||||||
Protein Name | ataxia telangiectasia mutated | ||||||||||||||||||||||||||||||||||||||||||||||||
Synonyms | AT1; ATA; ATC; ATD; ATDC; ATE; TEL1; TELO1; | ||||||||||||||||||||||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000388058 | ||||||||||||||||||||||||||||||||||||||||||||||||
InnateDB Gene | IDBG-70193 (ATM) | ||||||||||||||||||||||||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||||||||||||||||||||||
Function | Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism. Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FANCD2, NFKBIA, BRCA1, CTIP, nibrin (NBN), TERF1, RAD9 and DCLRE1C. May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Plays a role in replication-dependent histone mRNA degradation. Binds DNA ends. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation. Phosphorylates ATF2 which stimulates its function in DNA damage response. {ECO:0000269PubMed:10973490, ECO:0000269PubMed:12556884, ECO:0000269PubMed:14871926, ECO:0000269PubMed:15916964, ECO:0000269PubMed:16086026, ECO:0000269PubMed:16858402, ECO:0000269PubMed:17923702, ECO:0000269PubMed:19965871}. | ||||||||||||||||||||||||||||||||||||||||||||||||
Subcellular Localization | Nucleus. Cytoplasmic vesicle. Note=Primarily nuclear. Found also in endocytic vesicles in association with beta-adaptin. | ||||||||||||||||||||||||||||||||||||||||||||||||
Disease Associations | Ataxia telangiectasia (AT) [MIM:208900]: A rare recessive disorder characterized by progressive cerebellar ataxia, dilation of the blood vessels in the conjunctiva and eyeballs, immunodeficiency, growth retardation and sexual immaturity. Patients have a strong predisposition to cancer; about 30% of patients develop tumors, particularly lymphomas and leukemias. Cells from affected individuals are highly sensitive to damage by ionizing radiation and resistant to inhibition of DNA synthesis following irradiation. {ECO:0000269PubMed:10234507, ECO:0000269PubMed:10425038, ECO:0000269PubMed:10817650, ECO:0000269PubMed:10873394, ECO:0000269PubMed:7792600, ECO:0000269PubMed:8698354, ECO:0000269PubMed:8755918, ECO:0000269PubMed:8789452, ECO:0000269PubMed:8797579, ECO:0000269PubMed:8808599, ECO:0000269PubMed:8845835, ECO:0000269PubMed:9043869, ECO:0000269PubMed:9150358, ECO:0000269PubMed:9443866, ECO:0000269PubMed:9450874, ECO:0000269PubMed:9463314, ECO:0000269PubMed:9497252, ECO:0000269PubMed:9521587, ECO:0000269PubMed:9711876, ECO:0000269PubMed:9792409, ECO:0000269PubMed:9792410, ECO:0000269PubMed:9872980, ECO:0000269PubMed:9887333}. Note=The disease is caused by mutations affecting the gene represented in this entry.Note=Defects in ATM contribute to T-cell acute lymphoblastic leukemia (TALL) and T-prolymphocytic leukemia (TPLL). TPLL is characterized by a high white blood cell count, with a predominance of prolymphocytes, marked splenomegaly, lymphadenopathy, skin lesions and serous effusion. The clinical course is highly aggressive, with poor response to chemotherapy and short survival time. TPLL occurs both in adults as a sporadic disease and in younger AT patients.Note=Defects in ATM contribute to B-cell non-Hodgkin lymphomas (BNHL), including mantle cell lymphoma (MCL).Note=Defects in ATM contribute to B-cell chronic lymphocytic leukemia (BCLL). BCLL is the commonest form of leukemia in the elderly. It is characterized by the accumulation of mature CD5+ B-lymphocytes, lymphadenopathy, immunodeficiency and bone marrow failure. | ||||||||||||||||||||||||||||||||||||||||||||||||
Tissue Specificity | Found in pancreas, kidney, skeletal muscle, liver, lung, placenta, brain, heart, spleen, thymus, testis, ovary, small intestine, colon and leukocytes. | ||||||||||||||||||||||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 221 experimentally validated interaction(s) in this database.
They are also associated with 7 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||||||||||||||||||||||
InterPro |
IPR000403
Phosphatidylinositol 3-/4-kinase, catalytic domain IPR003151 PIK-related kinase, FAT IPR003152 PIK-related kinase, FATC IPR011009 Protein kinase-like domain IPR014009 PIK-related kinase IPR016024 Armadillo-type fold IPR021668 Telomere-length maintenance and DNA damage repair |
||||||||||||||||||||||||||||||||||||||||||||||||
PFAM |
PF00454
PF02259 PF02260 PF11640 |
||||||||||||||||||||||||||||||||||||||||||||||||
PRINTS | |||||||||||||||||||||||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||||||||||||||||||||||
SMART |
SM00146
|
||||||||||||||||||||||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||||||||||||||||||||||
SwissProt | Q13315 | ||||||||||||||||||||||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q13315 | ||||||||||||||||||||||||||||||||||||||||||||||||
TrEMBL | M0QXY8 | ||||||||||||||||||||||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||||||||||||||||||||||
Entrez Gene | 472 | ||||||||||||||||||||||||||||||||||||||||||||||||
UniGene | Hs.710771 | ||||||||||||||||||||||||||||||||||||||||||||||||
RefSeq | XP_005271618 | ||||||||||||||||||||||||||||||||||||||||||||||||
HUGO | HGNC:795 | ||||||||||||||||||||||||||||||||||||||||||||||||
OMIM | 607585 | ||||||||||||||||||||||||||||||||||||||||||||||||
CCDS | CCDS31669 | ||||||||||||||||||||||||||||||||||||||||||||||||
HPRD | 06347 | ||||||||||||||||||||||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||||||||||||||||||||||
EMBL | AP001925 AP005718 AY220758 BC137169 CH471065 KF455499 U26455 U33841 U55704 U55705 U55707 U55708 U55709 U55710 U55711 U55712 U55713 U55714 U55715 U55716 U55717 U55718 U55719 U55720 U55721 U55722 U55723 U55724 U55725 U55726 U55727 U55728 U55729 U55730 U55731 U55732 U55733 U55734 U55735 U55736 U55737 U55738 U55739 U55740 U55741 U55742 U55743 U55744 U55745 U55746 U55747 U55748 U55749 U55750 U55751 U55752 U55753 U55754 U55755 U55756 U55757 U67092 U82828 X91196 | ||||||||||||||||||||||||||||||||||||||||||||||||
GenPept | AAA86520 AAB38309 AAB38310 AAB65827 AAC50289 AAC51298 AAI37170 AAO26044 CAA62603 EAW67108 EAW67111 EAW67113 | ||||||||||||||||||||||||||||||||||||||||||||||||